1.Kenneally, C, Rosini, JM, Skrupky, LP, et al.Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 2007;132:418–424.
2.MacGowan, AP, Feeney, R, Brown, I, McCulloch, SY, Reeves, DS, Lovering, AM. Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea. J Antimicrob Chemother 1997;39:537–541.
3.Riley, TV. Antibiotic-associated diarrhoea. A costly problem. Pharmaco-economics 1996;10:1–3.
4.Wilcox, MH, Cunniffe, JG, Trundle, C, Redpath, C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996;34:23–30.
5.Spencer, RC. Clinical impact and associated costs of Clostridium difficile-associated disease. J Antimicrob Chemother 1998;41 Suppl C:5–12.
6.Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346–353.
7.Kuijper, EJ, Coignard, B, Tiill, P, et al.Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12 Suppl 6:2–18.
8.Warny, M, Pepin, J, Fang, A, et al.Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079–1084.
9.McDonald, LC, Killgore, GE, Thompson, A, et al.An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433–2441.
10.Zafar, AB, Gaydos, LA, Furlong, WB, Nguyen, MH, Mennonne, PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control 1998;26:588–593.
11.Oldfield EC 3rd. Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment. Rev Gastroenterol Disord 2004;4:186–195.
12.Eckstein, BC, Adams, DA, Eckstein, EC, et al.Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007;7:61.
13.Perencevich, EN, Stone, PW, Wright, SB, Carmeli, Y, Fisman, DN, Cosgrove, SE; Society for Healthcare Epidemiology of America. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121–1133.
14.Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006;44:1145–1149.
15.McDonald, LC, Coignard, B, Dubberke, E, Song, X, Horan, T, Kutty, PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140–145.
16.Charlson, ME, Sax, FL, MacKenzie, CR, Fields, SD, Braham, RL, Douglas, RG Jr. Resuscitation: how do we decide? A prospective study of physicians' preferences and the clinical course of hospitalized patients. JAMA 1986;255:1316–1322.
17.Riley, TV, Codde, JP, Rouse, IL. Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet 1995;345:455–456.
18.Ramaswamy, R, Grover, H, Corpuz, M, Daniels, P, Pitchumoni, CS. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996;91:460–464.
19.Sunenshine, RH, McDonald, LC. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 2006;73:187–197.